Medix Biochemica Revenue and Competitors
Estimated Revenue & Valuation
- Medix Biochemica's estimated annual revenue is currently $36.4M per year.
- Medix Biochemica's estimated revenue per employee is $155,000
Employee Data
- Medix Biochemica has 235 Employees.
- Medix Biochemica grew their employee count by 4% last year.
Medix Biochemica's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP Operations & Supply Chain | Reveal Email/Phone |
4 | VP Immunodiagnostic Reagents | Reveal Email/Phone |
5 | VP IVD Business Unit | Reveal Email/Phone |
6 | Director Operations | Reveal Email/Phone |
7 | Director Quality Assurance and Regulatory Affairs | Reveal Email/Phone |
8 | Medix Weston Site Lead: Director, Product Management – Biospecimens, Base Matrices, Biologicals | Reveal Email/Phone |
9 | Chief People Officer | Reveal Email/Phone |
10 | Director Product Management | Reveal Email/Phone |
Medix Biochemica Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Medix Biochemica?
Medix Biochemica develops, produces and markets monoclonal antibodies, antibody services and recombinant antigens for IVD industry as well as POC tests for human health care. MedixMAB product line includes monoclonal antibodies and antigens e.g. in cardiovascular, diabetes, fertility, infectious diseases, metabolism, serology, thyroid and tumor fields. In addition, Medix Biochemica offers flexible and customized services for diagnostic industry: recombinant antibody development, contract manufacturing of antibodies, antibody conjugation and coating of microplates. Actim rapid tests are easy to use bedside tests e.g. for pregnancy monitoring (detection of membrane rupture and screening for risk of preterm delivery), immunological FOB testing, screening of acute Pancreatitis and acute disease detecting (CRP, Influenza A&B, RSV, Noro). Diagnostics, Monoclonal antibodies, Antigens, Rapid tests
keywords:N/AN/A
Total Funding
235
Number of Employees
$36.4M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Medix Biochemica News
... LLC., Hologic CooperSurgical Abbott Laboratories, Medix Biochemica, Sera prognostics, Clinical Innovations, LLC., Biosynex,...
Qiagen Sciences, LLC., Hologic CooperSurgical Abbott Laboratories, Medix Biochemica, Sera prognostics, Clinical Innovations, LLC., Biosynex,...
... Membranes (PROM) Testing Market 2022 Industry Growth and Product Scope 2028 | Top Players as Abbott, Qiagen, Medix Biochemica, Hologic.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 1647 | 0% | N/A |